We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $7.22B
1-Year Est. Return 110.75%
This Fund
S&P 500
This Quarter Est. Return
-6.8%
1 Year Est. Return
+110.75%
3 Year Est. Return
+393.62%
5 Year Est. Return
+449.87%
10 Year Est. Return
+5,767.79%
AUM
$2.22B
AUM Growth
-$1.35B
Cap. Flow
+$165M
Cap. Flow %
7.43%
Top 10 Hldgs %
79.23%
Holding
26
New
8
Increased
4
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$147M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$68.3M
3
ANDV
Andeavor
ANDV
+$65M
4
IPXL
Impax Laboratories, Inc.
IPXL
+$59.7M
5
MPC icon
Marathon Petroleum
MPC
+$46.3M

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$93.8M
2
ALLE icon
Allegion
ALLE
+$93.5M
3
ENDP
Endo International plc
ENDP
+$77.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$55.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.62%
2 Communication Services 16.75%
3 Healthcare 16.5%
4 Energy 8.35%
5 Materials 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOR
26
PUT
DELISTED
QUESTCOR PHARMA INC
QCOR
– –
-370,000
Closed -$34.2M
1
2

Similar funds

GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $7.18B AUM 18.15% 1-Year Est. Return
TB
Thoma Bravo Chicago, Illinois $7.28B AUM 35.55% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return

Slate Path Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Slate Path Capital held 26 positions worth $2.22B, down 38% from $3.58B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Slate Path Capital deployed $165M of net new capital in Q3 2014, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Walgreens Boots Alliance: 2,245,000 shares worth $133M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 67% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $55.4M trimmed.

  • Slate Path Capital's largest Q3 2014 buy was Walgreens Boots Alliance: 2,245,000 shares worth $133M.
  • Slate Path Capital added most to Marathon Petroleum in Q3 2014, an estimated $46.3M increase.
  • Slate Path Capital's biggest Q3 2014 reduction was Intuitive Surgical, cutting an estimated $55.4M.
  • Slate Path Capital fully exited Trip.com Group in Q3 2014, selling an estimated $93.8M.
  • Slate Path Capital's ten largest holdings make up 79% of its $2.22B portfolio in Q3 2014.
  • Slate Path Capital opened 8 new positions and closed 6 in Q3 2014.
  • Slate Path Capital's portfolio value fell 38% quarter-over-quarter to $2.22B.

Based on Slate Path Capital's 13F filing for Q3 2014, filed 14 Nov 2014.